Ingrid Nilsson

Publications
Grants
Public outreach and news

Articles

Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(14):e2212476120
Cholinergic regulation of vascular endothelial function by human ChAT⁺ T cells
Tarnawski L; Shavva VS; Kort EJ; Zhuge Z; Nilsson I; Gallina AL; Martinez-Enguita D; Sahlgren BH; Weiland M; Caravaca AS; Schmidt S; Chen P; Abbas K; Wang F-H; Ahmed O; Eberhardson M; Farnert A; Weitzberg E; Gustafsson M; Kehr J; Malin SG; Hult H; Carlstrom M; Jovinge S; Olofsson PS
Article: BLOOD. 2022;140(4):388-400
Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin
Goncalves A; Su EJ; Muthusamy A; Zeitelhofer M; Torrente D; Nilsson I; Protzmann J; Fredriksson L; Eriksson U; Antonetti DA; Lawrence DA
Article: SCIENTIFIC REPORTS. 2020;10(1):22383
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood-brain barrier
Zeitelhofer M; Adzemovic MZ; Moessinger C; Stefanitsch C; Strell C; Muhl L; Brundin L; Fredriksson L; Olsson T; Eriksson U; Nilsson I
Article: EMBO REPORTS. 2020;21(7):e49343
VEGF-B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content
Moessinger C; Nilsson I; Muhl L; Zeitelhofer M; Heller Sahlgren B; Skogsberg J; Eriksson U
Article: SCIENTIFIC REPORTS. 2020;10(1):923
VEGF-B ablation in pancreatic β-cells upregulates insulin expression without affecting glucose homeostasis or islet lipid uptake
Ning FC; Jensen N; Mi J; Lindstrom W; Balan M; Muhl L; Eriksson U; Nilsson I; Nyqvist D
Article: PLOS ONE. 2018;13(7):e0201089
Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFRα signalling in vivo
Li H; Zeitelhofer M; Nilsson I; Liu X; Allan L; Gloria B; Perani A; Murone C; Catimel B; Neville AM; Scott FE; Scott AM; Eriksson U
Article: PLOS ONE. 2018;13(7):e0200649
Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CC^hum mice
Zeitelhofer M; Li H; Adzemovic MZ; Nilsson I; Muhl L; Scott AM; Eriksson U
Article: ACTA NEUROPATHOLOGICA. 2017;134(4):585-604
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun Y-Y; Yepes M; Kuan C-Y; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Article: CELL AND TISSUE RESEARCH. 2016;365(1):51-63
Expression of vascular endothelial growth factor (VEGF)-B and its receptor (VEGFR1) in murine heart, lung and kidney
Muhl L; Moessinger C; Adzemovic MZ; Dijkstra MH; Nilsson I; Zeitelhofer M; Hagberg CE; Huusko J; Falkevall A; Yla-Herttuala S; Eriksson U
Article: BIOLOGY OPEN. 2016;5(4):461-474
A role for PDGF-C/PDGFRα signaling in the formation of the meningeal basement membranes surrounding the cerebral cortex
Andrae J; Gouveia L; Gallini R; He L; Fredriksson L; Nilsson I; Johansson BR; Eriksson U; Betsholtz C
Article: ACTA NEUROPATHOLOGICA. 2016;131(3):453-464
Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration
Lewandowski SA; Nilsson I; Fredriksson L; Lonnerberg P; Muhl L; Zeitelhofer M; Adzemovic MZ; Nichterwitz S; Lawrence DA; Hedlund E; Eriksson U
Journal article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2016;108(3)
Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells (vol 107, djv209, 2015)
Hong J; Tobin NP; Rundqvist H; Li T; Lavergne M; Garcia-Ibanez Y; Qin H; Paulsson J; Zeitelhofer M; Adzemovic MZ; Nilsson I; Roswall P; Hartman J; Johnson RS; Ostman A; Bergh J; Poljakovic M; Genove G
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2015;107(10):djv209
Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells
Hong J; Tobin NP; Rundqvist H; Li T; Lavergne M; Garcia-Ibanez Y; Qin H; Paulsson J; Zeitelhofer M; Adzemovic MZ; Nilsson I; Roswall P; Hartman J; Johnson RS; Ostman A; Bergh J; Poljakovic M; Genove G
Article: FRONTIERS IN CELLULAR NEUROSCIENCE. 2015;9:456
tPA Deficiency in Mice Leads to Rearrangement in the Cerebrovascular Tree and Cerebroventricular Malformations
Stefanitsch C; Lawrence A-LE; Olverling A; Nilsson I; Fredriksson L
Article: FRONTIERS IN CELLULAR NEUROSCIENCE. 2015;9:385
Imatinib treatment reduces brain injury in a murine model of traumatic brain injury
Su EJ; Fredriksson L; Kanzawa M; Moore S; Folestad E; Stevenson TK; Nilsson I; Sashindranath M; Schielke GP; Warnock M; Ragsdale M; Mann K; Lawrence A-LE; Medcalf RL; Eriksson U; Murphy GG; Lawrence DA
Journal article: PLOS ONE. 2013;8(6):10.1371/annotation/dd60f2
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response
Z. Adzemovic M; Zeitelhofer M; Eriksson U; Olsson T; Nilsson I
Article: PLOS ONE. 2013;8(2):e56586
Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response
Adzemovic MZ; Zeitelhofer M; Eriksson U; Olsson T; Nilsson I
Article: AMERICAN JOURNAL OF PATHOLOGY. 2012;180(3):1136-1144
Platelet-Derived Growth Factor C Deficiency in C57BL/6 Mice Leads to Abnormal Cerebral Vascularization, Loss of Neuroependymal Integrity, and Ventricular Abnormalities
Fredriksson L; Nilsson I; Su EJ; Andrae J; Ding H; Betsholtz C; Eriksson U; Lawrence DA
Article: PLOS ONE. 2012;7(6):e38760
Imatinib Enhances Functional Outcome after Spinal Cord Injury
Abrams MB; Nilsson I; Lewandowski SA; Kjell J; Codeluppi S; Olson L; Eriksson U
Article: EMBO JOURNAL. 2010;29(8):1377-1388
VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts.
Nilsson I; Bahram F; Li X; Gualandi L; Koch S; Jarvius M; Söderberg O; Anisimov A; Kholová I; Pytowski B; Baldwin M; Ylä-Herttuala S; Alitalo K; Kreuger J; Claesson-Welsh L
Article: NATURE. 2010;464(7290):917-U136
Vascular endothelial growth factor B controls endothelial fatty acid uptake
Hagberg CE; Falkevall A; Wang X; Larsson E; Huusko J; Nilsson I; van Meeteren LA; Samen E; Lu L; Vanwildemeersch M; Klar J; Genove G; Pietras K; Stone-Elander S; Claesson-Welsh L; Yla-Herttuala S; Lindahl P; Eriksson U
Article: BLOOD. 2006;108(6):1877-1886
Platelet-derived growth factor receptor-β promotes early endothelial cell differentiation
Rolny C; Nilsson I; Magnusson P; Armulik A; Jakobsson L; Wentzel P; Lindblom P; Norlin J; Betsholtz C; Heuchel R; Welsh M; Claesson-Welsh L
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2006;26(5):1073-1078
Early lymph vessel development from embryonic stem cells.
Kreuger J; Nilsson I; Kerjaschki D; Petrova T; Alitalo K; Claesson-Welsh L
Article: EXPERIMENTAL CELL RESEARCH. 2005;308(2):381-393
Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-β signaling
Rolny C; Lu LG; Ågren N; Nilsson I; Roe C; Webb GC; Welsh M
Article: EXPERIMENTAL CELL RESEARCH. 2004;299(2):476-485
Differential activation of vascular genes by hypoxia in primary endothelial cells.
Nilsson I; Shibuya M; Wennström S
Article: FASEB JOURNAL. 2004;18(13):1507-1515
Vascular endothelial growth factor receptor-3 in hypoxia-induced vascular development
Nilsson I; Rolny C; Wu Y; Pytowski B; Hicklin D; Alitalo K; Claesson-Welsh L; Wennström S
Article: IN VIVO. 2003;17(1):1-4
Fetal antigen 1 (FA1) in the adult rat adrenal gland, ovary and pituitary gland.
Hedlund GP; Carlsson HE; Shieck E; Nilsson I; Lundblad C; Arons S; Iversen AK; Looman C; Jensen HE; Hau J
Show more

All other publications

Preprint: BIORXIV. 2021
Reduced myofibroblast transdifferentiation and fibrotic scarring in ischemic stroke after imatinib treatment
Zeitelhofer M; Stefanitsch C; Protzmann J; Torrente D; Adzemovic MZ; Lewandowski SA; Muhl L; Eriksson U; Nilsson I; Su EJ; Lawrence DA; Fredriksson L
Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):624-625
PDGFRA ANTAGONISM DAMPENS REACTIVE GLIOSIS AND SCAR FORMATION AFTER ISCHEMIC STROKE
Zeitelhofer M; Stefanitsch C; Adzemovic M; Sue J; Lewandowski S; Muhl L; Nilsson I; Lawrence D; Fredriksson L
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:930
Blocking PDGFR-a decreases multiple sclerosis-like neuroinflammation by inhibiting disruption of blood brain barrier integrity
Zeitelhofer M; Adzemovic MZ; Huang J; Stefanitsch C; Mossinger C; Hochmeister S; Strell C; Muhl L; Lassmann H; Kockum I; Fredriksson L; Olsson T; Nilsson I; Eriksson U
Meeting abstract: JOURNAL OF NEUROIMMUNOLOGY. 2014;275(1-2):32
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response
Adzemovic MZ; Zeitelhofer M; Eriksson U; Olsson T; Nilsson I
Editorial comment: EXPERIMENTAL NEUROLOGY. 2014;257:182-185
Response to the report, "A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury" by Sharp et al.
Abrams MB; Nilsson I; Kjell J; Lewandowski S; Codeluppi S; Eriksson U; Olson L

Grants

Growth-factor mediated regulation of blood vessel physiology - implications in several major diseases
Swedish Research Council
1 January 2017 - 31 December 2020
Exploring the Role of PDGF-CC in Vascular Permeability in the CNS
Swedish Research Council
1 July 2008 - 31 March 2010

Articles

All other publications

Grants

News from KI

Events from KI